Search - tctmd.com

Displaying 961 - 980 of 9101

Sort: Relevancy | Date

Presentation TCT 2024

TCT 547: Zero-Fluoroscopy Left Atrial Appendage Occlusion With the Watchman FLX Device

Presenter: Tarun Chakravarty

October 27, 2024

Presentation TCT 2024

TCT 533: Retrospective Comparison of Device Utilization for Left Atrial Appendage Occlusion: Amulet vs. Watchman

Presenter: Aqeel Khanani

October 27, 2024

Presentation TCT 2024

TCT 532: Impact of Pulmonary Ridge Swelling After Pulsed Field Ablation on Combined Left Atrial Appendage Occlusion

Presenter: Joseph Chan

October 27, 2024

Presentation TCT 2024

TCT 530: Fluoroscopic Evaluation of Device Compression During Left Atrial Appendage Occlusion With WATCHMAN FLX Pro

Presenter: Akshay Kamath

October 27, 2024

Presentation TCT 2024

TCT 210: Machine Learning Cluster Analysis Identifies Increased 12-Month Mortality Risk in Transcatheter Aortic Valve Replacement Recipients

Presenter: Thomas Meredith

October 27, 2024

Presentation TCT 2024

TCT 209: Deep Learning-Derived Body Composition Analysis Can Predict Long-Term Mortality Following Transcatheter Aortic Valve Replacement

Presenter: Chia-Hao Liu

October 27, 2024

Presentation TCT 2024

TCT 207: Investigation on the Performance of AI-Powered Fully Automated TAVR Planning Software

Presenter: Stefan Toggweiler

October 27, 2024

Presentation TCT 2024

TCT 206: Real-Time Predictive Modeling for Deployment of Transcatheter Aortic Valve Prostheses Using a Novel Reduced Order Model-Driven Computational Framework

Presenter: Imran Shah

October 27, 2024

Presentation TCT 2024

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

Presenter: Pablo Juan-Salvadores

October 27, 2024

Presentation TCT 2024

TCT 157: Long-Term Outcomes of Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerate Aortic Valve Homograft

Presenter: Shubhadarshini Pawar

October 27, 2024

Presentation TCT 2024

TCT 1577: TAVI-in-TAVI in an Emergency Scenario

Presenter: Lucas Lemos

October 27, 2024

Presentation TCT 2024

TCT 1566: TAVR-in-TAVR of Sapien in Evolut

Presenter: Daniel Zumerkorn Hassan

October 27, 2024

Presentation TCT 2024

TCT 1558: Redo-TAVR, SAPIEN 3 Resilia on a SAPIEN 3 THV

Presenter: Jair Basantes

October 27, 2024

Presentation TCT 2024

TCT 1491: TAVR-in-TAVR With a 29mm Sapien 3 Resilia Implanted Inside a 26mm Sapien 3

Presenter: Tulika Garg

October 27, 2024

Presentation TCT 2024

TCT 1360: Innovative Use of a New Generation Self-Expandable Valve in Redo-TAVR for a Degenerated Balloon-Expandable Prosthesis

Presenter: Roger Godinho

October 27, 2024

Presentation TCT 2024

My Perspective on Lifetime Management of Aortic Stenosis

Presenter: Adam Witkowski

October 27, 2024

Presentation TCT 2024

Why Didn’t We Do That? Top 5 Considerations to Prevent Complications and Promote Optimal Outcome for TAVR

Presenter: Sarah Heavey

October 27, 2024

Presentation TCT 2024

Why Didn’t We Do That? Top 5 Back to Basics Considerations To Prevent Complications and Promote Optimal Outcome for Transcatheter Mitral Therapy

Presenter: Asma Hussaini

October 27, 2024

Presentation TCT 2024

Why Are/Aren’t We Doing That? Top 5 Must-Have Post-Procedure Protocols

Presenter: Margaret Koes

October 27, 2024

Presentation TCT 2024

Here We Grow! What Do Teams Need to Know about the Current and Future State of Tricuspid Therapies?

Presenter: Carolina Pinheiro Rezende

October 27, 2024

Advertisement

TCT 547: Zero-Fluoroscopy Left Atrial Appendage Occlusion With the Watchman FLX Device

TCT 533: Retrospective Comparison of Device Utilization for Left Atrial Appendage Occlusion: Amulet vs. Watchman

TCT 532: Impact of Pulmonary Ridge Swelling After Pulsed Field Ablation on Combined Left Atrial Appendage Occlusion

TCT 530: Fluoroscopic Evaluation of Device Compression During Left Atrial Appendage Occlusion With WATCHMAN FLX Pro

TCT 210: Machine Learning Cluster Analysis Identifies Increased 12-Month Mortality Risk in Transcatheter Aortic Valve Replacement Recipients

TCT 209: Deep Learning-Derived Body Composition Analysis Can Predict Long-Term Mortality Following Transcatheter Aortic Valve Replacement

TCT 207: Investigation on the Performance of AI-Powered Fully Automated TAVR Planning Software

TCT 206: Real-Time Predictive Modeling for Deployment of Transcatheter Aortic Valve Prostheses Using a Novel Reduced Order Model-Driven Computational Framework

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

TCT 157: Long-Term Outcomes of Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerate Aortic Valve Homograft

TCT 1577: TAVI-in-TAVI in an Emergency Scenario

TCT 1566: TAVR-in-TAVR of Sapien in Evolut

TCT 1558: Redo-TAVR, SAPIEN 3 Resilia on a SAPIEN 3 THV

TCT 1491: TAVR-in-TAVR With a 29mm Sapien 3 Resilia Implanted Inside a 26mm Sapien 3

TCT 1360: Innovative Use of a New Generation Self-Expandable Valve in Redo-TAVR for a Degenerated Balloon-Expandable Prosthesis

My Perspective on Lifetime Management of Aortic Stenosis

Why Didn’t We Do That? Top 5 Considerations to Prevent Complications and Promote Optimal Outcome for TAVR

Why Didn’t We Do That? Top 5 Back to Basics Considerations To Prevent Complications and Promote Optimal Outcome for Transcatheter Mitral Therapy

Why Are/Aren’t We Doing That? Top 5 Must-Have Post-Procedure Protocols

Here We Grow! What Do Teams Need to Know about the Current and Future State of Tricuspid Therapies?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content